| http://dbpedia.org/ontology/abstract
|
Title 21 CFR Part 11 is the part of Title … Title 21 CFR Part 11 is the part of Title 21 of the Code of Federal Regulations that establishes the United States Food and Drug Administration (FDA) regulations on electronic records and electronic signatures (ERES). Part 11, as it is commonly called, defines the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records (Title 21 CFR Part 11 Section 11.1 (a)).s (Title 21 CFR Part 11 Section 11.1 (a)).
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm%3FCFRPart=11 +
, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm%3FCFRPart=11&showFR=1 +
, https://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm125125.pdf +
, https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm085281.htm +
, https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070266.pdf +
, https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM072322.pdf +
, https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm204012.htm +
|
| http://dbpedia.org/ontology/wikiPageID
|
7613634
|
| http://dbpedia.org/ontology/wikiPageLength
|
10018
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1105763716
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Pharmaceutical_industry +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Scientific_documents +
, http://dbpedia.org/resource/Category:Clinical_data_management +
, http://dbpedia.org/resource/Category:United_States_administrative_law +
, http://dbpedia.org/resource/Electronic_Signatures_in_Global_and_National_Commerce_Act +
, http://dbpedia.org/resource/Electronic_signature +
, http://dbpedia.org/resource/Computer_system +
, http://dbpedia.org/resource/Audit_trail +
, http://dbpedia.org/resource/Category:Pharmaceuticals_policy +
, http://dbpedia.org/resource/Contract_research_organization +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Category:Computer_law +
, http://dbpedia.org/resource/Electronic_medical_record +
, http://dbpedia.org/resource/Fax +
, http://dbpedia.org/resource/Food_and_Drug_Administration_%28United_States%29 +
, http://dbpedia.org/resource/Medical_device +
, http://dbpedia.org/resource/HACCP +
, http://dbpedia.org/resource/Category:Food_and_Drug_Administration +
, http://dbpedia.org/resource/Category:Regulation_of_medical_devices +
, http://dbpedia.org/resource/New_Drug_Application +
, http://dbpedia.org/resource/Code_of_Federal_Regulations +
, http://dbpedia.org/resource/Category:Code_of_Federal_Regulations +
, http://dbpedia.org/resource/Pharmaceutical_company +
, http://dbpedia.org/resource/Title_21_of_the_Code_of_Federal_Regulations +
, http://dbpedia.org/resource/Category:United_States_federal_law +
, http://dbpedia.org/resource/Electronic_lab_notebook +
, http://dbpedia.org/resource/Biologic_medical_product +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Computer_law +
, http://dbpedia.org/resource/Category:United_States_federal_law +
, http://dbpedia.org/resource/Category:Clinical_data_management +
, http://dbpedia.org/resource/Category:United_States_administrative_law +
, http://dbpedia.org/resource/Category:Scientific_documents +
, http://dbpedia.org/resource/Category:Code_of_Federal_Regulations +
, http://dbpedia.org/resource/Category:Pharmaceutical_industry +
, http://dbpedia.org/resource/Category:Pharmaceuticals_policy +
, http://dbpedia.org/resource/Category:Regulation_of_medical_devices +
, http://dbpedia.org/resource/Category:Food_and_Drug_Administration +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Part +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Title_21_CFR_Part_11?oldid=1105763716&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Title_21_CFR_Part_11 +
|
| owl:sameAs |
http://rdf.freebase.com/ns/m.0266s6h +
, http://www.wikidata.org/entity/Q7810055 +
, http://yago-knowledge.org/resource/Title_21_CFR_Part_11 +
, http://da.dbpedia.org/resource/21_CFR_Part_11 +
, http://dbpedia.org/resource/Title_21_CFR_Part_11 +
, https://global.dbpedia.org/id/4whsz +
|
| rdf:type |
http://dbpedia.org/class/yago/Work104599396 +
, http://dbpedia.org/class/yago/Publication106589574 +
, http://dbpedia.org/class/yago/Whole100003553 +
, http://dbpedia.org/class/yago/Object100002684 +
, http://dbpedia.org/class/yago/Artifact100021939 +
, http://dbpedia.org/class/yago/Creation103129123 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Product104007894 +
, http://dbpedia.org/class/yago/WikicatPublicationsOfTheUnitedStatesGovernment +
|
| rdfs:comment |
Title 21 CFR Part 11 is the part of Title … Title 21 CFR Part 11 is the part of Title 21 of the Code of Federal Regulations that establishes the United States Food and Drug Administration (FDA) regulations on electronic records and electronic signatures (ERES). Part 11, as it is commonly called, defines the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records (Title 21 CFR Part 11 Section 11.1 (a)).s (Title 21 CFR Part 11 Section 11.1 (a)).
|
| rdfs:label |
Title 21 CFR Part 11
|
